0001415889-24-015617.txt : 20240605
0001415889-24-015617.hdr.sgml : 20240605
20240605173403
ACCESSION NUMBER: 0001415889-24-015617
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240603
FILED AS OF DATE: 20240605
DATE AS OF CHANGE: 20240605
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VON ESCHENBACH ANDREW C.
CENTRAL INDEX KEY: 0001536529
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39813
FILM NUMBER: 241023150
MAIL ADDRESS:
STREET 1: C/O BLCO
STREET 2: 400 SOMERSET CORPORATE BLVD.
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TriSalus Life Sciences, Inc.
CENTRAL INDEX KEY: 0001826667
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 853009869
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6272 WEST 91ST AVENUE
CITY: WESTMINSTER
STATE: CO
ZIP: 80031
BUSINESS PHONE: 415 336 8917
MAIL ADDRESS:
STREET 1: 6272 WEST 91ST AVENUE
CITY: WESTMINSTER
STATE: CO
ZIP: 80031
FORMER COMPANY:
FORMER CONFORMED NAME: MedTech Acquisition Corp
DATE OF NAME CHANGE: 20200930
4
1
form4-06052024_090658.xml
X0508
4
2024-06-03
0001826667
TriSalus Life Sciences, Inc.
TLSI
0001536529
VON ESCHENBACH ANDREW C.
6272 W. 91ST AVE.
WESTMINSTER
CO
80031
true
false
false
false
0
Stock Option (right to buy)
11.34
2024-06-03
4
G
0
35000
0
D
2033-08-09
Common Stock
35000
0
D
Stock Option (right to buy)
11.34
2024-06-03
4
G
0
35000
0
A
2033-08-09
Common Stock
35000
35000
I
The Vons Living Trust U/T/A 4/3/2024 dated 4/3/2024
The Reporting Person transferred this option to The Vons Living Trust U/T/A 4/3/2024 dated 4/3/2024, Andrew von Eschenbach and Madelyn Giancaterino von Eschenbach, Co-Trustees (the "Trust") for no consideration. The Reporting Person and his spouse are co-trustees of the Trust, and the Reporting Person is the sole beneficiary of the Trust. The Reporting Person remains the beneficial owner of the securities held by the Trust.
The shares subject to this stock option vest in three equal annual installments from the vesting commencement date of August 10, 2023, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.
/s/ Sean Murphy, Attorney-in-Fact for Andrew von Eschenbach
2024-06-05